Innovation and Patent Law Reform: Hearings Before the Subcommittee on Courts, Civil Liberties, and the Administration of Justice of the Committee on the Judiciary, House of Representatives, Ninety-eighth Congress, Second Session, on H.R. 3285, H.R. 3286, and H.R. 3605 ... March 28, April 26, and June 6, 27, 1984, Part 1U.S. Government Printing Office, 1985 |
Contents
660 | |
674 | |
691 | |
700 | |
713 | |
720 | |
739 | |
754 | |
405 | |
450 | |
473 | |
481 | |
482 | |
491 | |
522 | |
595 | |
600 | |
650 | |
766 | |
814 | |
851 | |
859 | |
865 | |
870 | |
876 | |
900 | |
914 | |
Other editions - View all
Common terms and phrases
Abbreviated New Drug agreement agricultural chemical American ANDA animal drugs approval arbitration believe benefits beta blockers bill biotechnology Bolar Chairman claim commercial Commissioner companies compensation competition Congress corporations costs defensive patent disclosure drug application effective employee enactment exclusive expiration Federal fees FIFRA Fifth Amendment filing foreign herbicide industry innovation inventors issue June 27 KASTENMEIER legislation license licensor litigation manufacturers Monsanto MONSANTO CO MOSSINGHOFF Patent and Trademark patent application Patent Counsel patent extension patent holder patent infringement patent law patent owner patent protection patent rights patent system patent term extension patent term restoration patented process pesticide pharmaceutical prior art problem process patent proposed regulation regulatory review period research and development retroactive Section 202 statute statutory Subcommittee on Courts submitted taking testing tion trade secrets Trademark Office Tucker Act U.S. patent United United States Code validity WEGNER